Cytek Biosciences, Inc. (CTKB) vs Mesa Laboratories, Inc. (MLAB)
A side-by-side comparison of Cytek Biosciences, Inc. and Mesa Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTKB
Cytek Biosciences, Inc.
$5.63HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
MLAB
Mesa Laboratories, Inc.
$136.45HealthcareDelayed quote: Oct 6, 2026, 11:04 AM EDT
Total return — CTKB vs MLAB
growth of $100 · dividends reinvested · last 5yCTKB -67.5% (-20.1%/yr)MLAB -48.4% (-12.4%/yr)MLAB compounded faster over this window
CTKB MLAB
CTKB vs MLAB: by the numbers
- •MLAB is the larger company ($764M vs $726M market cap).
- •MLAB is profitable (1.92% net margin) while CTKB runs a net loss (-38.98%).
- •CTKB grew revenue faster over the past five years (13.37% vs 12.45% CAGR).
- •MLAB pays a dividend (0.45% yield), while CTKB has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CTKB | MLAB |
|---|---|---|
| P/E ratio | N/A | 162.44 |
| PEG ratio | N/A | 11.95 |
| P/S ratio | 3.51 | 3.06 |
| P/B ratio | 2.26 | 4.05 |
| EV / EBITDA | N/A | 18.36 |
| FCF yield | N/A | 6.92% |
Profitability
| Metric | CTKB | MLAB |
|---|---|---|
| Gross margin | 53.23% | 65.99% |
| Operating margin | -21.60% | 9.00% |
| Net margin | -38.98% | 1.92% |
| ROE | -25.03% | 2.54% |
| ROIC | -12.00% | 3.29% |
Dividends
| Metric | CTKB | MLAB |
|---|---|---|
| Dividend yield | N/A | 0.45% |
| Payout ratio | N/A | 76.19% |
Growth (annualized)
| Metric | CTKB | MLAB |
|---|---|---|
| Revenue CAGR (5Y) | 13.37% | 12.45% |
| EPS CAGR (5Y) | N/A | 13.08% |
| FCF CAGR (5Y) | N/A | 4.63% |
| Total return CAGR (5Y) | -23.16% | -13.52% |
Frequently asked
- Which has grown faster, CTKB or MLAB?
- Over the past five years, CTKB grew revenue faster — CTKB at a 13.37% CAGR versus MLAB at 12.45%.
- Does CTKB or MLAB pay a bigger dividend?
- MLAB pays a dividend (0.45% yield), while CTKB has no payments in the available dividend history.
- Is CTKB or MLAB more profitable?
- MLAB runs the higher net margin — CTKB at -38.98% versus MLAB at 1.92%.
- How have CTKB and MLAB total returns compared?
- Over the past 5 years, CTKB delivered -23.16% and MLAB delivered -13.52% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Mesa Laboratories P/E ratioMesa Laboratories dividend yieldCytek Biosciences ROEMesa Laboratories ROECytek Biosciences operating marginMesa Laboratories operating marginCytek Biosciences revenue growthMesa Laboratories revenue growthCytek Biosciences free cash flowMesa Laboratories free cash flow
Cytek Biosciences & Mesa Laboratories appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.